Galena Biopharma In The News
- Galena Biopharma Hires Joseph Lasaga as Vice President, Business Development and Alliance Management
- Galena Biopharma to Present at the Noble Financial Capital Markets 11th Annual Investor Conference
- Galena Biopharma Provides 2015 Outlook
- Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)
Galena is committed to ensuring eligible patients have access to our products. Learn more at GalenaPatientServices.com.